Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
4(31%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
23%
Ph not_applicable
2
15%
Ph phase_1
1
8%
Ph phase_2
7
54%

Phase Distribution

1

Early Stage

7

Mid Stage

3

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
7(53.8%)
Phase 3Large-scale testing
3(23.1%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(3)
Other(5)

Detailed Status

unknown5
Recruiting4
Completed3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (7.7%)
Phase 27 (53.8%)
Phase 33 (23.1%)
N/A2 (15.4%)

Trials by Status

completed323%
recruiting431%
unknown538%
not_yet_recruiting18%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT06977594Not Applicable

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Not Yet Recruiting
NCT05905315Phase 2

Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC

Recruiting
NCT03150576Phase 2

Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

Recruiting
NCT04161664Phase 2

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy

Recruiting
NCT04192253Phase 2

Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)

Recruiting
NCT02459457Phase 3

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Completed
NCT01918124Phase 2

A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer

Completed
NCT00035152Phase 3

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

Completed
NCT02570893Phase 3

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

Unknown
NCT02492503Phase 1

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Unknown
NCT02041338Phase 2

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

Unknown
NCT02195336Not Applicable

dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.

Unknown
NCT01347424Phase 2

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Unknown

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13